Premium
An Immunoradiometric Assay for Procoagulant Factor VIII Antigen: Results in Haemophilia, von Willebrand's Disease and Fetal Plasma and Serum
Author(s) -
Peake I. R.,
Bloom A. L.,
Giddings J. C.,
Ludlam C. A.
Publication year - 1979
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/j.1365-2141.1979.tb01131.x
Subject(s) - immunoradiometric assay , cryoprecipitate , haemophilia a , haemophilia , antigen , medicine , radioimmunoassay , immunology , coagulopathy , cord blood , prenatal diagnosis , endocrinology , andrology , gastroenterology , fetus , microbiology and biotechnology , platelet , pregnancy , biology , surgery , genetics
S ummary . An immunoradiometric assay (IRMA) has been developed based on the inhibitor which arose in a polytransfused severe haemophiliac. The two‐site IRMA measures antigens closely associated with the procoagulant parts of the factor VIII complex, which are termed FVIIIC antigens or FVIIICAG. FVIIICAG was present in normal plasma and also, at a slightly lower concentration, in normal serum. In 37 patients with haemophilia A, 36 had FVIIICAG levels of less than 10% of the normal plasma pool. In patients with von Willebrand's disease the levels of FVIIIC and FVIIICAG were in good agreement, both before and after treatment with cryoprecipitate or DDAVP. FVIIICAG was relatively stable in plasma at 37°C and could also be detected in cord and fetal serum. The assay is of potential value for detecting reduced levels of factor VIII, for carrier detection and for the prenatal diagnosis of haemophilia.